This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Hang on a second…

This CME Activity has expired and is no longer available for credit.

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Nephrology Experts in Residence: Focus on Hyperkalemia

Nephrology Experts in Residence: Focus on Hyperkalemia

Format

Clinical Review

Time to Complete

1 hour

Released

March 31, 2017

Expires

October 31, 2017
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / ANCC Contact Hour

Accredited Provider

Provided by the Annenberg Center for Health Sciences at Eisenhower

Commercial Supporter

This activity was supported by an educational grant from Relypsa, Inc.

Program Description

Biff F. Palmer, MD, and Robert Toto, MD, address challenges encountered when preventing and managing hyperkalemia in patients with chronic kidney disease, as well as how best to incorporate potassium binding therapy for hyperkalemia. The questions presented in this activity were posed by nephrologists who attended a related series of live, CME-certified meetings.

Check your own knowledge with 5 short assessment questions. Discover the top questions nephrologists have about hyperkalemia. Probe the details of a related patient case.

Intended Audience

This activity was developed for nephrologists, nephrology nurses, fellows, and other healthcare professionals who have an interest in the management of hyperkalemia.

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Summarize evidence-based recommendations on the use of renin-angiotensin-aldosterone system inhibitors in patients with chronic kidney disease
  • Describe risk factors for developing hyperkalemia
  • Compare and contrast current and emerging potassium-binding agents for the treatment of hyperkalemia
  • Identify opportunities to improve the management of sustained or recurrent hyperkalemia

Conflict Of Interest Disclosure Policy

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

Faculty

Biff F. Palmer, MD
Professor of Internal Medicine
UT Southwestern Medical Center
Dallas, TX

Dr. Palmer discloses the following:
Speakers Bureau: Relypsa

Robert Toto, MD
Associate Dean, Clinical and Translational Research
Director, Center for Translational Medicine
UT Southwestern Medical Center
Dallas, TX

Dr. Toto discloses the following:
Consultant: Amgen, Bayer, Boehringer-Ingelheim, Quintiles, Relypsa, ZS-Pharma

Planners' and Managers' Disclosures

Annenberg Center for Health Sciences
John Bayliss, VP
, Business Development, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Additional content planners
Bethany Pellegrino, MD (peer reviewer) discloses the following:
Research Support: GlaxoSmithKline

The following have no significant relationship to disclose:
Gregory Scott, PharmD, RPh (medical writer)

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurses

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

A maximum of 1.00 contact hours may be earned for successful completion of this activity.

Disclaimer

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

Instructions

This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material, reflecting on its implications in your practice, and completing the assessment component.

Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.

Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.

Contact Information

For help or questions about this Internet activity please contact Annenberg Continuing Education:
ce@annenberg.net
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday

Privacy Policy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/

myCME privacy policy
Add to Queue